Correlation Between Gain Therapeutics and Fennec Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Gain Therapeutics and Fennec Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Gain Therapeutics and Fennec Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Gain Therapeutics and Fennec Pharmaceuticals, you can compare the effects of market volatilities on Gain Therapeutics and Fennec Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Gain Therapeutics with a short position of Fennec Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Gain Therapeutics and Fennec Pharmaceuticals.
Diversification Opportunities for Gain Therapeutics and Fennec Pharmaceuticals
-0.59 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between Gain and Fennec is -0.59. Overlapping area represents the amount of risk that can be diversified away by holding Gain Therapeutics and Fennec Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Fennec Pharmaceuticals and Gain Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Gain Therapeutics are associated (or correlated) with Fennec Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Fennec Pharmaceuticals has no effect on the direction of Gain Therapeutics i.e., Gain Therapeutics and Fennec Pharmaceuticals go up and down completely randomly.
Pair Corralation between Gain Therapeutics and Fennec Pharmaceuticals
Given the investment horizon of 90 days Gain Therapeutics is expected to under-perform the Fennec Pharmaceuticals. In addition to that, Gain Therapeutics is 1.04 times more volatile than Fennec Pharmaceuticals. It trades about -0.21 of its total potential returns per unit of risk. Fennec Pharmaceuticals is currently generating about 0.31 per unit of volatility. If you would invest 436.00 in Fennec Pharmaceuticals on September 1, 2024 and sell it today you would earn a total of 170.00 from holding Fennec Pharmaceuticals or generate 38.99% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Very Weak |
Accuracy | 100.0% |
Values | Daily Returns |
Gain Therapeutics vs. Fennec Pharmaceuticals
Performance |
Timeline |
Gain Therapeutics |
Fennec Pharmaceuticals |
Gain Therapeutics and Fennec Pharmaceuticals Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Gain Therapeutics and Fennec Pharmaceuticals
The main advantage of trading using opposite Gain Therapeutics and Fennec Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Gain Therapeutics position performs unexpectedly, Fennec Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Fennec Pharmaceuticals will offset losses from the drop in Fennec Pharmaceuticals' long position.Gain Therapeutics vs. Tff Pharmaceuticals | Gain Therapeutics vs. Eliem Therapeutics | Gain Therapeutics vs. Inhibrx | Gain Therapeutics vs. Enliven Therapeutics |
Fennec Pharmaceuticals vs. Molecular Partners AG | Fennec Pharmaceuticals vs. MediciNova | Fennec Pharmaceuticals vs. Anebulo Pharmaceuticals | Fennec Pharmaceuticals vs. Champions Oncology |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Commodity Directory module to find actively traded commodities issued by global exchanges.
Other Complementary Tools
Fundamental Analysis View fundamental data based on most recent published financial statements | |
Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
Global Correlations Find global opportunities by holding instruments from different markets |